INSIGHT MM & the benefits of real-world evidence

Jim Omel discusses his participation in the INSIGHT MM & the benefits of real-world evidence with patients participating in trials in multiple myeloma.

Jim has been living with multiple myeloma since 1997 and is an active member of the INSIGHT MM steering committee, as well as one of the lead authors of the study. When his disease relapsed in 2000 following a stem cell transplant, Jim retired from his medical practice to begin a new career as a patient advocate. An unofficial “myeloma expert,” Jim uses his medical knowledge to help people with multiple myeloma via a vast network of organizations, including the National Cancer Institute, the Central Nebraska Myeloma Support Group, the U.S. Food, and Drug Administration’s (FDA) Myeloma Steering Committee and the Alliance Cooperative Group, among others.

Liked it? Take a second to support healthprofessionalradio on Patreon!

0 Comments

Leave a Reply

You must be logged in to post a comment.